Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study
about
Clinical Implications of Antiviral Resistance in InfluenzaManagement of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignanciesAvian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitorThe pharmacological management of severe influenza infection - 'existing and emerging therapies'.Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 HemagglutininsEfficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantationViral Respiratory Infections of Adults in the Intensive Care Unit.A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region.Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system.
P2860
Q26782746-8EB5CD56-85E1-4E64-8D01-206530E808B9Q26853131-63EDD605-D3A9-4CCC-8B5A-7B9C7C72D367Q28543086-76042FDC-E5A4-49D1-B1C0-6DB0D9435D80Q30243907-E28C17CD-501F-48E0-AFA4-46DEDD4019D1Q30392944-EA9C4A8C-60F0-40FF-AAD5-AEF80A844EB0Q34058036-FD2D75BC-77F0-4D1A-A811-CC86269548B9Q35952190-A23BF6DC-B33E-4CF9-994A-9311579349C5Q36965855-4097C998-26FC-49B7-B12B-10C37BA5F3DFQ38491990-09CAB10A-212E-498D-AFBE-35B197A8F22CQ39414987-C4F8950F-E253-4E59-9079-BE585F589C0FQ42199847-1BBC1F17-1975-494F-AC54-840E3B188DEBQ47593385-7EB91CC1-B7D2-4691-B47B-A8C8E3BD6963
P2860
Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety and pharmacokinetics of ...... er, single-arm, phase II study
@ast
Safety and pharmacokinetics of ...... er, single-arm, phase II study
@en
type
label
Safety and pharmacokinetics of ...... er, single-arm, phase II study
@ast
Safety and pharmacokinetics of ...... er, single-arm, phase II study
@en
prefLabel
Safety and pharmacokinetics of ...... er, single-arm, phase II study
@ast
Safety and pharmacokinetics of ...... er, single-arm, phase II study
@en
P2093
P2860
P50
P921
P356
P1476
Safety and pharmacokinetics of ...... er, single-arm, phase II study
@en
P2093
Amanda F Peppercorn
Bruno Francois
Choy Y Man
David Brealey
Denis Garot
Francisco Alvarez-Lerma
Henry H Zhao
José A Lorente
Phillip J Yates
Rafael Mánez
P2860
P304
P356
10.1093/INFDIS/JIT467
P407
P577
2013-08-27T00:00:00Z